Lets look at what we currently know
The glucagon receptor component does not appear to cause significant glucose-raising effects in the context of GLP-1 co-activation, suggesting that the three receptor pathways balance each other in important ways
The companion guide, BPC-157 in Thailand: Clinical-Grade, Doctor-Prescribed, covers the practical side: quality differences, dosing considerations, oral vs injectable, legality, and how to access it in Thailand.
The only limitation here would that you dont want to overwhelm your liver, which will already be processing the dead fat cells, so as always, drink responsibly
When administered properly under medical supervision, serious adverse effects are rare